211. Hypoplastic left heart syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 22 /  Drugs : 29 - (DrugBank : 9) / Drug target genes : 5 - Drug target pathways : 14

Hypoplastic left heart syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
IDDiseases (Sorted by drug repositionability)
211Hypoplastic left heart syndrome
13Multiple sclerosis/Neuromyelitis optica
85Idiopathic interstitial pneumonia
86Pulmonary arterial hypertension
84Sarcoidosis
51Scleroderma
212Tricuspid atresia
210Single Ventricle
41Giant cell arteritis
66IgA nephropathy
78Hypopituitarism
113Muscular dystrophy
49Systemic lupus erythematosus
96Crohn disease
2Amyotrophic lateral sclerosis
46Malignant rheumatoid arthritis
83Addison disease
47Buerger disease
220Rapidly progressive glomerulonephritis
30Distal myopathy
81Congenital adrenal hyperplasia